Page last updated: 2024-10-27

fenofibrate and Kahler Disease

fenofibrate has been researched along with Kahler Disease in 2 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Research Excerpts

ExcerptRelevanceReference
"Fenofibrate significantly reduced viability due to apoptosis induction in all investigated myeloma and lymphoma cell lines in a dose-dependent manner, whereas healthy control cells were less sensitive."3.85 ( Schmeel, FC; Schmeel, LC; Schmidt-Wolf, IGH, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmeel, LC1
Schmeel, FC1
Schmidt-Wolf, IGH1
Kurtoglu, M1
Philips, K1
Liu, H1
Boise, LH1
Lampidis, TJ1

Other Studies

2 other studies available for fenofibrate and Kahler Disease

ArticleYear
    Anticancer research, 2017, Volume: 37, Issue:7

    Topics: Anticarcinogenic Agents; Apoptosis; beta Catenin; Carbocyanines; Cell Line, Tumor; Fenofibrate; Huma

2017
High endoplasmic reticulum activity renders multiple myeloma cells hypersensitive to mitochondrial inhibitors.
    Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:1

    Topics: Antineoplastic Agents; Calcium; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Death; Cell Line, Tu

2010